Development of a contemporary bleeding risk model for elderly warfarin recipients

Area of Science:

• Cardiology
• Geriatrics
• Pharmacology

Background:

• Warfarin is commonly prescribed for atrial fibrillation (AF) in elderly patients.
• Accurate bleeding risk assessment is crucial for safe warfarin use.
• Existing risk models may not reflect contemporary practice or adequately stratify elderly populations.

Purpose of the Study:

• To develop and validate a contemporary bleeding risk model for elderly AF patients on warfarin.
• To guide clinical decision-making regarding warfarin therapy in this population.
• To improve the safety and efficacy of anticoagulation management.

Main Methods:

• Utilized chart-abstracted data from the National Registry of Atrial Fibrillation combined with Medicare claims.
• Employed a split-sample technique for variable selection and model development.
• Validated the model and compared its performance against existing bleeding risk models using c-statistics and Kaplan-Meier curves.

Main Results:

• The final model included eight variables: age (≥70 years), gender, remote bleeding, recent bleeding, alcohol/drug abuse, diabetes, anemia, and antiplatelet use.
• Developed risk categories (low, moderate, high) with distinct bleeding rates (0.9%, 2.0%, 5.4%).
• The new model demonstrated improved risk stratification compared to existing models.

Conclusions:

• A validated, contemporary bleeding risk model for elderly AF patients on warfarin was developed using a large, national dataset.
• The model incorporates additional risk factors and offers enhanced risk stratification for the elderly population.
• This tool can guide clinical practice for safer warfarin management in older adults with AF.